Cogoluegnes, S., Kovachka, S., Dubois, T., Würth, R., Donato, E., Trumpp, A., . . . Mus-Veteau, I. (2026). Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers. Translational oncology.
Cita Chicago Style (17a ed.)Cogoluegnes, Sarah, et al. Inhibition of PTCH1 Drug Efflux Activity Enhances Chemotherapy Efficacy Against Triple Negative Breast Cancers. Translational oncology, 2026.
Cita MLA (9a ed.)Cogoluegnes, Sarah, et al. Inhibition of PTCH1 Drug Efflux Activity Enhances Chemotherapy Efficacy Against Triple Negative Breast Cancers. Translational oncology, 2026.
Precaución: Estas citas no son 100% exactas.